Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto De Lima Lopes

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Cancer Management and Research|June 16, 2017
Can biosimilars help achieve the goals of US health care reform?Ralph Boccia, Ira Jacobs, Robert Popovian, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2011
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: meta-analysis of phase III trialsGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
Cancer Chemotherapy and Pharmacology|June 16, 2012
Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine mattersGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Health Perspective in Sarcomas and Other Rare CancersVaia Florou, Antonio G Nascimento, Ashish Gulia, et al.
Expert Review of Clinical Pharmacology|October 24, 2013
Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copiesAnna Kaltenboeck, Genia Long, Eleanor Hayes-Larson, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
The Road to Addressing Noncommunicable Diseases and Cancer in Global Health PolicyHeath Catoe, Jordan Jarvis, Sudeep Gupta, et al.
Journal of Global Oncology|July 19, 2017
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?Cinthia Leite Frizzera Borges Bognar, Brittany L Bychkovsky, Gilberto de Lima Lopes
Current Opinion in Oncology|March 20, 2013
Pharmacoeconomic issues in head and neck oncologyJonas A de Souza, Gilberto de Lima Lopes, Ezra E W Cohen
Pharmacoeconomics - Open|January 20, 2021
A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung CancerNan Qiao, Ralph Insinga, Gilberto de Lima Lopes Junior, et al.
Cancer Letters|December 31, 2013
A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptorTing Yu, Zhicai Zhou, Yuguang Mu, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Cancer Management and Research|June 16, 2017
Can biosimilars help achieve the goals of US health care reform?Ralph Boccia, Ira Jacobs, Robert Popovian, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2011
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: meta-analysis of phase III trialsGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
Cancer Chemotherapy and Pharmacology|June 16, 2012
Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine mattersGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Health Perspective in Sarcomas and Other Rare CancersVaia Florou, Antonio G Nascimento, Ashish Gulia, et al.
Expert Review of Clinical Pharmacology|October 24, 2013
Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copiesAnna Kaltenboeck, Genia Long, Eleanor Hayes-Larson, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
The Road to Addressing Noncommunicable Diseases and Cancer in Global Health PolicyHeath Catoe, Jordan Jarvis, Sudeep Gupta, et al.
Journal of Global Oncology|July 19, 2017
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?Cinthia Leite Frizzera Borges Bognar, Brittany L Bychkovsky, Gilberto de Lima Lopes
Current Opinion in Oncology|March 20, 2013
Pharmacoeconomic issues in head and neck oncologyJonas A de Souza, Gilberto de Lima Lopes, Ezra E W Cohen
Pharmacoeconomics - Open|January 20, 2021
A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung CancerNan Qiao, Ralph Insinga, Gilberto de Lima Lopes Junior, et al.
Cancer Letters|December 31, 2013
A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptorTing Yu, Zhicai Zhou, Yuguang Mu, et al.
Pageof 10